Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.
Iannetta M, Zingaropoli MA, Latronico T, Pati I, Pontecorvo S, Prezioso C, Pietropaolo V, Cortese A, Frontoni M, D'Agostino C, Francia A, Vullo V, Mastroianni CM, Liuzzi GM, Ciardi MR.
Iannetta M, et al. Among authors: prezioso c.
Sci Rep. 2019 Jan 22;9(1):311. doi: 10.1038/s41598-018-36535-5.
Sci Rep. 2019.
PMID: 30670793
Free PMC article.